Sign in
Stories
Corporate Moves in Health and Finance
Share
Corporate Financial Updates and Complian...
Healthcare Companies Grant Equity Induce...
Adicet Bio Awards Stock Options
Adicet Bio Grants Inducement Stock Optio...
Amgen's Weight-Loss Drugs Market Entranc...
Overview
API
Puma Biotechnology grants inducement stock to new hires to enhance oncology innovation, while Dole plc sells its equity stake in Progressive Produce LLC for $120.25 million. Nutrien receives TSX approval for a share repurchase program, and Civitas Resources, Inc. announces a share repurchase agreement with NGP Tap Rock Holdings, LLC.
Ask a question
How does the approval of Nutrien's share repurchase program reflect on the company's financial health and shareholder relations?
How might Puma Biotechnology's focus on oncology innovation impact the cancer treatment landscape?
What implications could the sale of Progressive Produce LLC have on Dole plc's future financial strategies?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Nov 2023
Dec 2023
Jan 2024
Feb 2024
Coverage
bnnbr